This site is intended for healthcare professionals only
LoginRegister
Merck in Talks to Acquire Revolution Medicines in USD 28-32 Billion Oncology DealMSD Phase 3 trial of head and neck cancer treatment meets primary endpoint
Biotechnology to Drive Indias Next Industrial Revolution: Dr. Jitendra SinghBiotechnology to Drive India's Next Industrial Revolution: Dr. Jitendra Singh
Fortis Healthcare to Raise Rs 1,500 Crore Through NCDsFortis Healthcare to Raise Rs 1,500 Crore Through NCDs
Declare Cancer a Notifiable Disease, Bring Cancer Drugs Under Price Control: Parliamentary PanelAnti cancer medicines now under Schedule H2 of Drugs Rules, Here is what it means
ZydusZydus receives USFDA nod for Paliperidone ER Tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg
Lupin Manufacturing Solutions, PolyPeptide Group forge long term Peptide allianceAlkem Labs inks pact with Sonnet BioTherapeutics to develop, commercialise drug candidate for...
Pulse Pharma Gets CDSCO Panel Nod to Manufacture, Market Aripiprazole Oral SolutionSoon, harsher penalties for submitting false data for drug approval
Medicines worth Rs 6,975 crore in MRP terms sold through JAKs in last 10 yearsAre certain Hair Loss drugs causing suicidal thoughts? EU drugs regulator begins review
Novartis concludes acquisition of Tourmaline BioSwitzerland COMCO competition commission terminates Novartis probe without consequences
Govt extends deadline for submitting applications under PLI SchemeAkums unveils Dual-Action Heartburn Relief Chewable Tablets for India
EU gives marketing authorization for Novavax updated 2024-2025 Nuvaxovid COVID vaccineEU gives marketing authorization for Novavax updated 2024-2025 Nuvaxovid COVID vaccine
TN Health Releases Round 2 Online Counselling Schedule for M Pharm Admissions, check detailsTN Health Releases Round 2 Online Counselling Schedule for M Pharm Admissions, check details
X